Beyond static pores: A dynamic mechanism of antimicrobial action

For nearly a century, antibiotics have saved millions of lives. This cornerstone of modern medicine is now under threat since antibiotic resistance is rising at an alarming pace, threatening a return to the preantibiotic era (1). In 2019 alone, antibiotic resistance directly contributed to over a million deaths (2), a statistic that demands the development of new therapeutic strategies. Among the most promising alternatives are antimicrobial peptides (AMPs), innate immune molecules that act via a unique, nonspecific physical mechanism difficult for bacteria to evade.

Historically, AMPs have been thought to kill bacteria by forming well-defined structural pores that perforate the membrane and cause cell death (3, 4). However, some biophysical studies (5–8) suggest that many potent AMPs remain peripherally bound to the membrane surface, unable to fully span the bilayer. This creates a paradox: how can peptides that do not insert across the membrane cause the rapid ion permeabilization required for antimicrobial activity? In a recent publication in this journal, Koynarev et al. (9) provide a new answer. They show that structural pores are not required for effective ion transport, demonstrating that AMPs can induce transient water channels that facilitate rapid permeabilization. This work offers a new blueprint for the design of next-generation antibiotics.

The Membranolytic Mechanism of Action of AMPs

Several structural models have been proposed to explain how AMPs perforate the membrane, most notably the toroidal pore, barrel-stave, and carpet models (4). The toroidal model (Fig. 1, cyan channel) suggests peptides induce a high-curvature pore lined by both peptides and lipid headgroups. Meanwhile, the barrel-stave model (Fig. 1, blue channel) posits that peptides insert transversally to form a rigid protein-lined channel. In the carpet model (10) (Fig. 1, purple peptide), peptides bind electrostatically to the membrane surface and align parallel to it, covering it in a carpet-like arrangement. When their surface concentration exceeds a critical threshold, the AMPs disrupt the lipid bilayer in a detergent-like manner, forming transient toroidal pores and ultimately causing membrane disintegration into micelles. Crucially, these models all share a nonnegotiable prerequisite: AMPs must insert perpendicularly and assemble into stable, transmembrane structures. This requirement, however, is in conflict with some biophysical evidence. Static techniques like solid-state NMR (6–8) and small angle scattering (SAXS/SANS) (5) showed that potent AMPs, including the $\alpha$-helical LL-37 and Indolicidin, only partitioned peripherally, lying flat on the outer membrane leaflet. This contradiction—between the necessary transmembrane insertion for the models and the observed peripheral binding in reality—persisted largely because traditional techniques could not simultaneously capture the peptide’s static position and the rapid functional kinetics of ion leakage.

Fig. 1.

The membranolytic mechanisms of action of AMPs. These peptides kill bacteria by permeabilizing the cell membrane. The toroidal pore model (cyan channel) suggests that peptides insert perpendicularly but cooperatively induce a high-curvature defect, lining the pore with both peptide residues and bent lipid headgroups. The barrel-stave pore model (blue channel) proposes that amphipathic peptides insert perpendicularly and self-assemble to form a stable, peptide-lined channel. In the carpet-like model (purple peptides), peptides accumulate on the membrane surface and, upon reaching a threshold concentration, disrupt the bilayer in a detergent-like manner, leading to micellization or transient pore formation. The transient water channel model (left velvet-colored channel), presented in the study by Koynarev et al. (9), shows that peripherally bound AMPs can act as catalysts to accelerate lipid flip-flop-the rapid transmembrane movement of individual lipid molecules. This localized, dynamic instability creates short-lived, water-filled defects sufficient for rapid ion permeabilization, without stable peptide assembly or deep membrane penetration. Ion transport for each mechanism is shown as a green trace (the path of a green sphere).

The work by Koynarev et al. (9) provides a new blueprint for AMP action, showing that stable structural pores may not be necessary for rapid ion permeabilization.

Real-Time Kinetics Reveal a New Functional Pathway

Koynarev et al. (9) address this methodological question based on the capabilities of Time-Resolved Small Angle X-ray Scattering (TR-SAXS). This technique provides a unique window into the earliest, fastest kinetic events, allowing researchers to track the influx of monoatomic ions (Na⁺/Cl⁻) across the membrane in millisecond time scales while simultaneously resolving the peptide position and the membrane structure. By applying a sudden osmotic shock (rapidly mixing the salt-free vesicles with a high-salt solution), they could directly observe that peripheral binding is functionally potent. Although confined to the outer leaflet, AMPs, such as Indolicidin and LL-37, facilitate rapid ion transport, allowing ions to flood into the vesicles until the internal salt concentration matches that outside, all in just a few tens of milliseconds. This finding therefore raises a critical question: how can a membrane be so effectively permeabilized in the absence of a stable pore?

The Transient Water Channel Blueprint

The explanation for this mechanism lies not in a stable structure but in the dynamic instability of the membrane itself. Through molecular dynamics (MD) simulations, the authors identified the precise molecular mechanism. As illustrated in Fig. 1 (velvet-colored peptide), their simulations show that peripherally bound AMPs act as local catalysts, significantly accelerating lipid flip-flop-the transmembrane diffusion of individual lipid molecules from one leaflet to the other. This rapid and localized lipid movement creates a short-lived water-filled defect. This defect functions as a transient water channel, sufficient for the passage of hydrated ions and effectively short-circuiting the cell. A key implication of this model is that no complex structural assembly is required. Instead, the peptide acts as a catalyst, exploiting the membrane’s inherent dynamic properties to create momentary defects for rapid ion exchange. This mechanism offers a fresh, dynamic perspective on AMP action that contrasts with the previously dominant structural pore models. A theoretical diffusion model provides further support for this dynamic model. When parameterized using the ion diffusion coefficient extracted from the MD simulations, it perfectly reproduced the experimentally measured TR-SAXS kinetics.

The critical role of membrane dynamics was confirmed experimentally. When the authors repeated the experiments using vesicles composed of stiff, saturated lipids (which are known to have a low rate of intrinsic lipid flip-flop), the permeabilization effect vanished for all AMPs tested. This indicates that a membrane must be inherently dynamic and susceptible to flip-flop for the peripheral AMP mechanism to work. Conversely, when the fluid phase membranes were used, the ion transport was often too rapid to measure, reinforcing the link between membrane fluidity, lipid dynamics, and AMP potency.

Conclusion

The work by Koynarev et al. (9) provides a new blueprint for AMP action, showing that stable structural pores may not be necessary for rapid ion permeabilization. This insight shifts the focus from static pore formation to the design of peptides that act as catalysts for localized membrane instability and lipid flip-flop. By emphasizing membrane dynamics, this work opens the door to strategies that exploit lipid composition and fluidity to enhance AMP potency. Peptide design can now prioritize catalytic efficiency and precise membrane localization, potentially enabling selective targeting of pathogenic cells while sparing host membranes. This research also enables the de novo design of AMPs, guiding the engineering of entirely new peptides that exploit transient membrane defects to achieve rapid and selective antimicrobial activity.